Clinical trial
Use of Labeled Glucose to Study Lymphocyte Replication and Survival in…
NCT00001651 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00001651 |
|---|---|
| Title | Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients |
| Official title | Studies of Lymphocyte Kinetics Using Stable Isotopes |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | HIV, Healthy Volunteers |
| Intervention type | Other |
| Interventions | [6, 6-2H2]-glucose |
| Enrollment | 54 |
| Start date | Feb 25, 1998 |
| Primary completion | Jan 1, 2020 |
| Completion | May 29, 2020 |
| First posted | Nov 4, 1999 |
| Last update posted | Jun 1, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: